Dr Wong Chew Hooi is currently Medical Director for Oncology at Pfizer, where she is responsible for developing and executing medical strategies for lung cancer portfolio across Pfizer Emerging Market region. In her current role, she actively works with local country colleagues in Latin America, Africa-Middle East and Asia to advance and accelerate the launch of lung cancer therapies in these countries. She started her career in Pfizer 8 years ago as Medical Scientific Liaison in Singapore before assuming the role of Medical Lead for Oncology, Singapore.
Prior to joining Pfizer, Chew Hooi had the experience as a Postdoctoral Research Fellow in Genome Institute of Singapore, A*STAR as well as a Project Manager at Singapore Advanced Biologics.
Dr Wong Chew Hooi holds a Phd in Cancer Molecular Biology from the NUS Graduate School for Integrative Sciences and a BSc degree in Life Sciences from the National University of Singapore.